rxstat › Drug prices › Methyldopa

Methyldopa price in Canada

Partial shortage

Source: Health Canada shortage reports · Updated Nov 5, 2026

Methyldopa 250 mg tablet costs about $0.16 to $0.21 per tablet on public drug plan price lists across 7 provinces, before the pharmacy's dispensing fee.

Some Methyldopa products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 20, 2026.

Price by province

Strength and formBCABSKONNBNSNL
250 mg Tabletper tablet$0.21$0.20$0.20$0.16$0.17$0.18$0.20
125 mg Tabletper tablet$0.14$0.13$0.13$0.10$0.11$0.12$0.14
500 mg Tabletper tablet$0.37$0.34$0.34$0.26$0.29$0.31$0.35
Plan coverageCoveredCoveredCoveredCoveredCoveredCoveredPrice list

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

British Columbia: 3 products
  • Methyldopa 125 mg Tablet · AAP
    DIN 00360252 · $0.14/tablet · Covered
  • Methyldopa 250 mg Tablet · AAP
    DIN 00360260 · $0.21/tablet · Covered
  • Methyldopa 500 mg Tablet · AAP
    DIN 00426830 · $0.37/tablet · Covered
Alberta: 3 products
  • Methyldopa 125 mg Tablet · AAP
    DIN 00360252 · $0.13/tablet · Covered
  • Methyldopa 250 mg Tablet · AAP
    DIN 00360260 · $0.20/tablet · Covered
  • Methyldopa 500 mg Tablet · AAP
    DIN 00426830 · $0.34/tablet · Covered
Saskatchewan: 3 products
  • Methyldopa 125 mg Tablet · AAP
    DIN 00360252 · $0.13/tablet · Covered
  • Methyldopa 250 mg Tablet · AAP
    DIN 00360260 · $0.20/tablet · Covered
  • Methyldopa 500 mg Tablet · AAP
    DIN 00426830 · $0.34/tablet · Covered
Ontario: 6 products
  • Methyldopa 125 mg Tablet · A A Pharma Inc.
    DIN 00360252 · $0.10/tablet · Covered
  • Methyldopa 250 mg Tablet · A A Pharma Inc.
    DIN 00360260 · $0.16/tablet · Covered
  • Methyldopa 500 mg Tablet · A A Pharma Inc.
    DIN 00426830 · $0.26/tablet · Covered
  • Aldomet Tab 125mg 125 mg Tablet · Merck Sharp & Dohme Canada, Division of Merck Frosst Canada
    DIN 00016551 · no listed price · Not covered
  • Aldomet Tab 250mg 250 mg Tablet · Merck Sharp & Dohme Canada, Division of Merck Frosst Canada
    DIN 00016578 · no listed price · Not covered
  • Aldomet Tab 500mg 500 mg Tablet · Merck Sharp & Dohme Canada, Division of Merck Frosst Canada
    DIN 00016586 · no listed price · Not covered
New Brunswick: 3 products
  • Methyldopa 125 mg Tablet · AAP
    DIN 00360252 · $0.11/tablet · Covered
  • Methyldopa 250 mg Tablet · AAP
    DIN 00360260 · $0.17/tablet · Covered
  • Methyldopa 500 mg Tablet · AAP
    DIN 00426830 · $0.29/tablet · Covered
Nova Scotia: 6 products
  • Methyldopa 125 mg Tablet · AAP
    DIN 00360252 · $0.12/tablet · Covered
  • Methyldopa 250 mg Tablet · AAP
    DIN 00360260 · $0.18/tablet · Covered
  • Methyldopa 500 mg Tablet · AAP
    DIN 00426830 · $0.31/tablet · Covered
  • Aldomet Tab 125mg 125 mg Tablet · LIH
    DIN 00016551 · no listed price · Not covered
  • Aldomet Tab 250mg 250 mg Tablet · LIH
    DIN 00016578 · no listed price · Not covered
  • Aldomet Tab 500mg 500 mg Tablet · LIH
    DIN 00016586 · no listed price · Not covered
Newfoundland and Labrador: 4 products
  • Methyldopa 125 mg Tablet · AAP
    DIN 00360252 · $0.14/tablet · Price list
  • Aldomet Tab 250mg 250 mg Tablet · MSD
    DIN 00016578 · $0.20/tablet · Price list
  • Methyldopa 250 mg Tablet · AAP
    DIN 00360260 · $0.21/tablet · Price list
  • Methyldopa 500 mg Tablet · AAP
    DIN 00426830 · $0.35/tablet · Price list

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · BC PharmaCare Low Cost Alternative list (Nov 5, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026) · Newfoundland and Labrador Interchangeable Drug Products Formulary (Oct 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
1 / 3
In shortage since
Oct 19, 2026
Est. full return
Nov 20, 2026
Reports on file
6
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Reports by product

The DIN is printed on your prescription label.

Active shortage
METHYLDOPA
125MG · TABLET · AA PHARMA INC
DIN 00360252 · since Oct 19, 2026, est. end Nov 20, 2026 · Disruption of the manufacture of the drug.
Resolved
METHYLDOPA
500MG · TABLET · AA PHARMA INC
DIN 00426830 · ended Dec 3, 2024 · Disruption of the manufacture of the drug.
Resolved
METHYLDOPA
500MG · TABLET · AA PHARMA INC
DIN 00426830 · ended Jan 19, 2024 · Disruption of the manufacture of the drug.
Resolved
METHYLDOPA
500MG · TABLET · AA PHARMA INC
DIN 00426830 · ended Apr 24, 2023 · Disruption of the manufacture of the drug.
Resolved
METHYLDOPA
500MG · TABLET · AA PHARMA INC
DIN 00426830 · ended Jan 16, 2023 · Disruption of the manufacture of the drug.
Resolved
METHYLDOPA
250MG · TABLET · AA PHARMA INC
DIN 00360260 · ended Oct 21, 2022 · Disruption of the manufacture of the drug.

What's happening

Methyldopa is currently affected by an active shortage report filed with Health Canada by AA PHARMA INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Methyldopa is classified under “ANTIADRENERGIC AGENTS, CENTRALLY ACTING” (ATC C02AB).

Recent changes

Common questions

How much does Methyldopa cost in Canada?

Methyldopa 250 mg tablet costs about $0.16 to $0.21 per tablet on public drug plan price lists across 7 provinces, before the pharmacy's dispensing fee.

Is Methyldopa covered by provincial drug plans?

On the public plans' own lists: British Columbia: covered; Alberta: covered; Saskatchewan: covered; Ontario: covered; New Brunswick: covered; Nova Scotia: covered; Newfoundland and Labrador: price list. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Methyldopa be back in stock in Canada?

The latest manufacturer estimate is Nov 20, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Methyldopa in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antiadrenergic agents, centrally acting)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.